{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T14:04:32Z","timestamp":1768226672507,"version":"3.49.0"},"reference-count":29,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Varicella-zoster virus (VZV)-induced hemophagocytic lymphohistiocytosis (HLH) is a rare but fatal complication, particularly in immunocompromised hosts. We present an 11-year-old boy with IgA vasculitis who developed severe VZV-HLH complicated by disseminated intravascular coagulation (DIC), acute liver failure and persistent lymphocytopenia. A multimodal therapeutic approach that combining high-dose acyclovir, intravenous immunoglobulin (IVIG), therapeutic plasma exchange (TPE), reduced-dose etoposide (75 mg\/m\u00b2), and dexamethasone achieved rapid disease remission. This case demonstrates synergistic risk of HLH when VZV infection overlaps with IgA vasculitis, likely via compounded immune dysregulation. This case suggests that when varicella zoster virus infection overlaps with IgA vasculitis, it may synergistically increase the risk of HLH through aggravated immune dysregulation. In infection-triggered HLH, step-wise immunomodulatory therapy has a key role. What\u2019s more, lymphocytopenia may be used as a biomarker to assess disease severity and recovery, and this finding emphasizes the need for long-term immune monitoring. This case provides valuable insights into the pathogenesis and management of VZV related HLH in rheumatic and immune diseases.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1675483","type":"journal-article","created":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T08:17:57Z","timestamp":1768205877000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Synergistic hyperinflammation in IgA vasculitis complicated by varicella-induced HLH: a case report"],"prefix":"10.3389","volume":"16","author":[{"given":"Xiaoli","family":"He","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lina","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deyuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhongqiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guoyan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.32394\/pe.76.52","article-title":"Chickenpox in Poland in 2020","volume":"76","author":"Bogusz","year":"2023","journal-title":"Przegl Epidemiol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26041132","article-title":"Advances and perspectives in the management of varicella-zoster virus infections","volume":"26","author":"Andrei","year":"2021","journal-title":"Molecules"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2014.3065","article-title":"Varicella-zoster virus infections in patients treated with fingolimod: risk assessment and consensus recommendations for management","volume":"72","author":"Arvin","year":"2015","journal-title":"JAMA Neurol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"15","DOI":"10.2147\/ITT.S176383","article-title":"Varicella zoster virus vaccines: an update","volume":"8","author":"Gabutti","year":"2019","journal-title":"Immunotargets Ther"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1007\/82_2010_41","article-title":"Varicella zoster virus immune evasion strategies","volume":"342","author":"Abendroth","year":"2010","journal-title":"Curr Top Microbiol Immunol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(13)61048-x","article-title":"Adult haemophagocytic syndrome","volume":"383","author":"Ramos-Casals","year":"2014","journal-title":"Lancet"},{"key":"B7","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1146\/annurev-pathol-020117-043625","article-title":"Hemophagocytic lymphohistiocytosis","volume":"13","author":"Al-Samkari","year":"2018","journal-title":"Annu Rev Pathol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2020.101515","article-title":"Hemophagocytic lymphohistiocytosis: An update on pathogenesis, diagnosis, and therapy","volume":"34","author":"Griffin","year":"2020","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019000936","article-title":"Macrophage activation syndrome: a potentially fatal complication of rheumatic disorders","volume":"85","author":"Sawhney","year":"2001","journal-title":"Arch Dis Child"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019000936","article-title":"Pediatric hemophagocytic lymphohistiocytosis","volume":"135","author":"Canna","year":"2020","journal-title":"Blood"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/s41435-020-0098-4","article-title":"The genetics of macrophage activation syndrome","volume":"21","author":"Schulert","year":"2020","journal-title":"Genes Immun"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.771619","article-title":"Pathogenesis of igA vasculitis: an up-to-date review","volume":"12","author":"Song","year":"2021","journal-title":"Front Immunol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-03-278127","article-title":"How I treat hemophagocytic lymphohistiocytosis","volume":"118","author":"Jordan","year":"2011","journal-title":"Blood"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1002\/art.39332","article-title":"2016 Classification criteria for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: A european league against rheumatism\/American college of rheumatology\/Paediatric rheumatology international trials organisation collaborative initiative","volume":"68","author":"Ravelli","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"B15","article-title":"Haemophagocytic syndrome in rheumatic patients. A systematic review","volume":"16","author":"Atteritano","year":"2012","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1389710","article-title":"Heterogeneity of macrophage activation syndrome and treatment progression","volume":"15","author":"Dong","year":"2024","journal-title":"Front Immunol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1099468","article-title":"Case Report: Parvovirus B19 infection complicated by hemophagocytic lymphohistiocytosis in a heart-lung transplant patient","volume":"14","author":"Zhang","year":"2023","journal-title":"Front Immunol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.pathol.2019.09.011","article-title":"Epstein-Barr virus-associated T- and NK-cell lymphoproliferative diseases: an update and diagnostic approach","volume":"52","author":"Hue","year":"2020","journal-title":"Pathology"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1111\/ped.12523","article-title":"Hemophagocytic lymphohistiocytosis secondary to Varicella zoster infection in a child with Henoch\u2013Sch\u00f6nlein purpura","volume":"57","author":"Gur","year":"2015","journal-title":"Pediatr Int"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1007\/s13730-019-00415-2","article-title":"Efficacy of plasma exchange with a high dose of acyclovir for disseminated varicella infection","volume":"9","author":"Aoyagi","year":"2019","journal-title":"CEN Case Rep"},{"key":"B21","doi-asserted-by":"publisher","first-page":"e25351","DOI":"10.1097\/md.0000000000025351","article-title":"Primary varicella-zoster virus infection of the immunocompromised associated with acute pancreatitis and hemophagocytic lymphohistiocytosis","volume":"100","author":"B\u00e9rar","year":"2021","journal-title":"Med (Baltimore)"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.12998\/wjcc.v6.i13.659","article-title":"Successful rescue of acute liver failure and hemophagocytic lymphohistiocytosis following varicella infection: A case report and review of literature","volume":"6","author":"Zhang","year":"2018","journal-title":"World J Clin Cases"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciac649","article-title":"Hemophagocytic lymphohistiocytosis associated with cytomegalovirus infection: 5 cases and a systematic review of the literature","volume":"76","author":"Chevalier","year":"2023","journal-title":"Clin Infect Dis"},{"key":"B24","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/s10875-024-01653-5","article-title":"Impaired STING activation due to a variant in the E3 ubiquitin ligase AMFR in a patient with severe VZV infection and hemophagocytic lymphohistiocytosis","volume":"44","author":"Thomsen","year":"2024","journal-title":"J Clin Immunol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1007\/s12026-024-09526-0","article-title":"New mutations and new phenotypes: a case of Major Histocompatibility Complex Class II Deficiency","volume":"72","author":"Li","year":"2024","journal-title":"Immunol. Res."},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1187959","article-title":"Hemophagocytic inflammatory syndrome in ADA-SCID: report of two cases and literature review","volume":"14","author":"Fratini","year":"2023","journal-title":"Front Immunol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2020.04.086","article-title":"Lymphopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A systemic review and meta-analysis","volume":"96","author":"Zhao","year":"2020","journal-title":"Int J Infect Dis"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.20471\/acc.2023.62.01.10","article-title":"Is lymphopenia a predictor of mortality in patients with Covid-19","volume":"62","author":"K\u0131l\u0131c","year":"2023","journal-title":"Acta Clin Croat"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.109922","article-title":"Predictive value of peripheral lymphocyte subsets for the disease progression in patients with sepsis","volume":"117","author":"Tang","year":"2023","journal-title":"Int Immunopharmacol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1675483\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T08:17:58Z","timestamp":1768205878000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1675483\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,12]]},"references-count":29,"alternative-id":["10.3389\/fimmu.2025.1675483"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1675483","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,12]]},"article-number":"1675483"}}